MT-RNR1 POCT
Point-of-care molecular testing (POCT) of MT-RNR1 for avoidance of aminoglyocside induced hearling loss in neonates (Artificial Buccal swabs)
Device verification samples for CYP2C19 (POCT) – 1 SET
One set of 8 patient-like swab-based materials designed to help implement and verify POCT devices for CYP2C19 testing. See https://www.emqn.org/our-eqa-schemes/poct/ for more information.